Early Covid-19 Research Isn’t As Inclusive As It Should Be

Experts agree that people of color must be adequately represented in coronavirus vaccine and drug trials. It’s unclear whether that’s happening.

A man stands outside Moderna headquarters in Cambridge, Massachusetts on May 18, 2020. The New England Journal of Medicine recently published the phase 1 results of Moderna’s promising mRNA vaccine. Photo: Joseph Prezioso/AFP/Getty Images